DalsnaFinance › Analyst accuracy › HSBC › PFE target
HSBC downgrades Pfizer stock rating on lack of near-term catalysts
HSBC downgraded Pfizer to Hold from Buy, while also reducing its price target to $28 from $32.
A fact about what HSBC published, as reported by Investing.com, not a recommendation from Dalsna Finance; HSBC is not affiliated with this site.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.